12/05/2013
Federal Register Notice: FDA proposed collection of information, “Over-the-Counter Drugs; Labeling Requirements,” has ...11/27/2013
Federal Register Notice: FDA is reopening the comment period for the notice of availability entitled Draft Guidance for Industry o...11/27/2013
Federal Register Notice: FDA is reopening the comment period to 12/11 for the Draft Guidance for Industry on Generic Drug User Fee...11/27/2013
Federal Register Notice: FDA’s Risk Communications Advisory Committee will meet 12/17 from 9 a.m. to 5 p.m. at the FDA White...11/27/2013
Federal Register Notice: CDER and CBER are announcing a pilot project to evaluate the Clinical Data Interchange Standard Consortiu...11/26/2013
Federal Register Notice/Final rule: FDA is withdrawing approval of a Fleming Laboratories NADA for an arsanilic acid Type A medica...11/25/2013
Federal Register Notice: FDA is making available Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gen...